neurocognitive disorders: cognition and aging · •58 year old woman presents to clinic with chief...

66
DOS CME Course 2011 1 Oxtober 2010 1 Confidential Neurocognitive Disorders: Cognition and Aging Anne Vanderbilt, MSN, CNS, CNP Clinical Nurse Specialist Nursing Education and Professional Practice Geriatrics Cleveland Clinic © Cleveland Clinic 2014

Upload: others

Post on 21-Apr-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

DOS CME Course 2011 1 Oxtober 2010 1 Confidential

Neurocognitive Disorders: Cognition and Aging

Anne Vanderbilt, MSN, CNS, CNP

Clinical Nurse Specialist Nursing Education and Professional Practice Geriatrics Cleveland Clinic

© Cleveland Clinic 2014

Page 2: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• 58 year old woman presents to clinic with chief complaint of memory loss.

• She reports having difficulty remembering appointments, forgetting names and misplacing things.

• She complains of difficulty concentrating.

• This has been occurring gradually for the past 3-4 months but has been worse the past 1 month.

• She is very worried because her mother had Alzheimer’s disease when she was in her 80’s.

• What more information do you want to know?

Ms. A

Page 3: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• PMH: HTN, Hyperlipidemia

• PSH: Cesarean delivery x 2

• Medications: – Amlodipine 5mg daily – Simvasatin 20mg daily – Zoloft 50mg daily – Tylenol PM - prn

• SH:married with 2 teenage children, drinks 1-2 glasses of wine / day,does not smoke, no drugs, reports a lot of stress in her life right now

• VS 152/84, HR 82 R, R 20 Weight 92 kg, 171 cm

• Physical Exam is Normal

Ms. A

Page 4: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Objectives

• Describe age related changes in cognition

• Define mild cognitive impairment

• Discuss types of dementia

• State strategies to preserve cognition function as we age

Page 5: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

What is Normal Aging? “You can only perceive real beauty in a person as they get older” Anouk Aimee

• Highly individualized

• Biological vs. chronological age

• Effect of exercise and lifestyle

Source: Microsoft clip art

Page 6: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Normal Age Related Changes

Page 7: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Reduced brain size

• Reduced nerve cells

• Decreased cerebral blood flow

• Slower nerve conduction velocity resulting in slower reflexes and delayed response to stimuli

Age related structural changes - Neurology

Source: radiology assistant. Alzheimer Centre and Image Analysis Centre, Vrije Universiteit Medical Center, Amsterdam and the Rijnland Hospital, Leiderdorp, The Netherlands

Page 8: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Personality is unchanged – But may be expressed more openly

• Intelligence is unchanged – Crystallized intelligence

–Ability to use skills, knowledge, and experience – Fluid intelligence or fluid reasoning

–Capacity to think logically and solve problems in novel situations – Independent of acquired knowledge

• Early phases of learning are more difficult

• Working memory is reduced

Age Related Cognitive Changes

Page 9: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Depression and Stress

• Sleep deprivation

• Alcohol and substances abuse

• Head Injury

• Stroke

• Vitamin Deficiency – B12, folate

• Hypothyroidism

• Infection; ie Tertiary syphilis, HIV

• Delirium

• MEDICATIONS: anticholinergics, antihistamines, benzodiazepines, muscle relaxants, hypnotics and opioids

Conditions that Affect Cognition OTHER than Dementia

Page 10: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• National Institute of Aging and Alzheimer’s Association Criteria 2011

• Must meet all 4 criteria

1. Concern regarding a change in cognition – Concern may be from patient, family or clinician

2. Impairment in one or more cognitive domain -- usually episodic memory – decline in performance over time

3. INTACT level of functional abilities

4. NO DEMENTIA

Mild Cognitive Impairment (MCI)

Page 11: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Some cognitive decline is measurable on advanced tests such as the Montreal Cognitive Assessment (MOCA)

• Some difficulty with complex tasks found at work

• Often need to write more things down and / or work at a slower pace

More on Mild Cognitive Impairment

Page 12: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Does MCI progress to Dementia ?

• Probably but not always

• Rate of progression from MCI to Alzheimer’s Disease – 6 to 25% per year

(American Academy of neurology – AAN - 2001)

• Some studies suggest 80% conversion in 6 yrs

• Some evidence that MCI is Pre- Dementia

Page 13: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Memory loss is a natural part of aging

• Alzheimer’s disease is more common in women

• Inability to maintain attention and changing level of consciousness is a symptom of dementia

• Diabetes is a risk factor for dementia

• There are more than 10 types of dementia

Myths vs. Facts about Dementia

Page 14: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Umbrella term describing symptoms

• A “syndrome” of impaired cognition caused by brain dysfunction (loss of intellectual capacity)

• A progressive cognitive decline that occurs in a normal state of consciousness and in the absence of other acute or subacute disorders

Dementia Defined

Source: radiology assistant.

Page 15: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Memory impairment

• One or more of the following cognitive disturbances: (a) aphasia (language disturbance) (b) apraxia (impaired ability to carry out motor activities ) (c) agnosia (failure to recognize or identify objects) (d) disturbance in executive functioning (i.e., planning, organizing,

sequencing, abstracting)

• Significant impairment in functioning and a significant decline from a previous level

• Deficits do not occur exclusively during the course of a delirium

Dementia (DSM-IV) Complex Medical Syndrome

Page 16: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

DSM 5 – Criteria for Neurocognitive Disorders Mild or Major

• No longer use the term “Dementia”

• Memory loss is no longer a requirement for diagnosis

1. Cognitive decline from a previous level of performance in one or more of domains

2. Deficits in testing or equivalent clinical evaluation

3. The cognitive deficits are sufficient to interfere with independence

4. The cognitive deficits do not occur exclusively in the context of a delirium.

5. The cognitive deficits are not primarily attributable to another mental disorder

Page 17: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Primarily a disease of late life > 65: 10% > 85: 60%

• Many types – Alzheimer’s – Vascular – Lewy Body – Frontotemporal – Normal pressure hydrocephalus – Mixed

• Estimated that 1/2 people with dementia are undiagnosed

• Primary reason for institutionalization

Background of Dementia

Page 18: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Alzheimer’s disease 50-80%

• Vascular dementia 10-15%

• Dementia with Lewy Bodies

• Frontotemporal Dementias 10 %

• Normal Pressure Hydrocephalus (NPH)

• Mixed Dementia

Types of Dementias

Page 19: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Most common form in the elderly

• 5.4 million in the U.S.

• Beta-amyloid protein plaques build up between neurons

• Tau proteins build up – Inside the cells and cause neurofibrillary tangles

• Begins in the hippocampus (memory center)

• Gradually moves to other areas of the brain

• Decreased acetylcholine

• Impaired glucose metabolism

• Slow progressive disease – Average is 8 to 10 years but may be much longer

Alzheimer’s Disease (AD)

http://www.alz.org/braintour/plaques_tangles.asp

Presenter
Presentation Notes
Lois Alzheimer’s 1906 – 100 years of Alzheimer's
Page 20: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Biomarkers in Cerebrospinal fluid – Amyloid 42 (A42) detected

• PET scan with radiotracer PDG detects glucose uptake

• Functional MRI

Recent Research / Diagnosis

Source: radiology assistant. Alzheimer Centre and Image Analysis Centre, Vrije Universiteit Medical Center, Amsterdam and the Rijnland Hospital, Leiderdorp, The Netherlands

Page 21: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• National Institute on Aging (NIA) and the Alzheimer’s Association

• Three stages of Alzheimer’s Disease 1. Preclinical disease 2. MCI due to AD 3. Alzheimer’s DEMENTIA

• Role of Imaging and biomarkers under investigation – Not used routinely for clinical practice

New Criteria and Guidelines 2011

Page 22: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• < 1 % of cases

• Onset of cognitive symptoms < 65 – usually much earlier

• Presenile genes PS1, PS2

• More rapid course of decline

Early Onset Alzheimer’s Dementia “The Great American Love Goddess.”

Source: classicmoviepeople.com

Page 23: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Age (over 65)

• Female gender

• African American (2x) or Hispanic (1.5x)

• APOE 4 allele (lipoprotein gene) – May be a factor in 20-25%

• Low education

• Depression

• History of head injury

• Heart disease

• Diabetes Vascular Disease

• Smoking

Alzheimer’s Risks Factors

2013 Alzheimer’s Disease Facts and Figures

Page 24: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Impairment of blood flow to parts of the brain – Multi-infarct – TIA

• Symptoms similar to Alzheimer’s – Memory loss less pronounced – Decision making more affected

• May have step-like progression symptoms instead of slow progressive decline

• ‘PURE’ vascular dementia is uncommon – 10-15%

• MIXED vascular dementia is VERY common

Vascular Dementia

Source: Alzheimer’s Association

Page 25: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Lewy bodies deposits in areas of the brain

• Presents with impairment in attention and alertness

• Usually visual hallucinations in early stages

• Muscle rigidity and tremors similar to Parkinson’s disease

• Younger patients

• Faster course of disease

Dementia with Lewy Bodies

www.ahaf.org/alzdis/about/AnatomyBrain.htm

Presenter
Presentation Notes
Extrapyramidal=outside pyramidal tracts, “marked by abnormal involuntary movements, alterations in muscle tone, postural disturbances” (Miller-Keane, 1997) Dysarthria=impaired speech r/t impaired muscular control Substantia Nigra: Function: Controls Voluntary Movement Produces the Neurotransmitter Dopamine Regulates Mood Location: The substantia nigra is located in the mesencephalon (mid brain) region of the brain. It is part of the basal ganglia.
Page 26: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

ie primary progressive aphasia, Pick’s disease and progressive supranuclear palsy

•Younger age onset typically 45 – 65 yo – more common than AD in the younger population

•Prominent behaviors – Personal neglect, disinhibition, hyperorality

•Speech disorders – Aphasia and echolalia

•Rapid decline

Frontotemporal Dementia (FTD)

Page 27: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Clinical Triad

1. Gait apraxia (paramount symptom)

2. Urinary incontinence

3. Confusion

• Neuroimage – Pronounced ventricular enlargement

• Clinical improvement with shunt

• No reliability predicting shunt effects

Normal Pressure Hydrocephalus (NPH)

Source: hydrocephalus association

Page 28: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Mixed Dementia

Chertkow H CMAJ 2008;178:316-321

Page 29: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• AD can only truly be diagnosed by autopsy

• CT scan or MRI can identify dementia

• PET scan or fMRI should be ordered routinely for diagnosis of dementia

• Neuropsych testing should be ordered routinely for diagnosis of dementia

• Alzheimers Disease can be diagnosed accurately by history and exclusion of other pathologies

How to make a Diagnosis? True or False

Page 30: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Report of the Quality Standards Subcommittee of the American Academy of Neurology 2001 – Standards from 1994

• American Geriatric Society – 2010

• History: Always obtain from family or other caregiver: – Progression of symptoms – Head injury – Alcohol or other substance use – Depression

• Comprehensive physical and neurologic examination

• Assess functional status – ADL and IADL

• Evaluate mental status for attention, immediate and delayed recall, remote memory, executive function, depression. – Mini-Cog, Minimental status exam. Montreal Cognitive Assessment – Number of animals named in 1 minute

– 18 is average; less than 10 markedly abnormal, MMSE, – Geriatric Depression Scale, PHQ – 9

Guidelines for Diagnosis

Page 31: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Part of comprehensive mental status examination including

• Orientation

• Attention and concentration

• Memory

• Judgment

• Executive control functions

• Speech and language

• Presence of delusions, hallucinations

• Mood and affect

Cognitive Assessment

Page 32: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,
Page 33: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Clock Draw Test

Source: Journal of American Board of Family Medicine 2003

Page 34: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

PHQ- R

Page 35: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

More Advanced Test • Cognition

1. Folstein Mini-Mental Status 2. Montreal Cognitive Assessment www.mocatest.org/pdf_files/test/MoCA-Test-English_7_1.pdf

3. St Louis University Mental Status Assessment medschool.slu.edu/agingsuccessfully/pdfsurveys/slumsexam_05.pdf

Page 36: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Labs – CBC, THS, B12, folate, serum calcium, liver and kidney function tests,

electrolytes

• Serologic test for syphilis (selectively) • Glucose and HIV for patients at risk • Non - Contrast CT or MRI • Likelihood of detecting structural lesions is increased with

– Onset age <60 years – Focal (unexplained) neurologic signs or symptoms – Abrupt onset or rapid decline (weeks to months) – Predisposing conditions (eg, metastatic cancer or anticoagulants)

• Neuroimaging may detect the 5% of patients with clinically significant structural lesions that would otherwise be missed

• FDG-PET scans approved by Medicare for atypical presentation of course of AD in which frontotemporal dementia diagnosis is suspected

Labs and Imaging

Page 37: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Activities of daily living (ADL)

• Bathing

• Dressing

• Transferring

• Eating

• Toileting

• Continence

Functional Assessment Instrumental activities of daily living (IADL)

• Telephone

• Shopping

• Food prep

• Housekeeping

• Laundry

• Transportation

• Medications

• Finances

Page 38: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

All behavior has meaning and is used to communicate or express unmet needs and/or difficulty managing stress

• Restlessness

• Anxiety

• Irritability

• Anger outbursts

• Verbal and physical aggression

• Wandering

• Repetitive vocalizations

• Hoarding, rummaging

• Delusions

• Hallucinations

Behavior Assessment

Page 39: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Ms. A • 58 yo woman presents to clinic

with chief complaint of memory loss.

• She reports having difficulty remembering appointments, forgetting names and misplacing things.

• She complains of difficulty concentrating.

• This has been occurring gradually for the past 3-4 months but has been worse the past 1 month.

• She is very worried because her mother had Alzheimer’s disease when she was in her 80’s.

• PMH: HTN, Hyperlipidemia

• PSH: Cesarean delivery x 2

• Medications: – Amlodipine 5mg daily – Simvasatin 20mg daily – Zoloft 50mg daily – Tylenol PM - prn

• Social history – Married with 2 teenage children,

drinks 1-2 glasses of wine / day, does not smoke,no drugs, reports a lot of stress in her life right now

• VS 152/84, HR 82 R, R 20 Weight 92 kg, 171 cm

• Physical Exam is normal

Page 40: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Delirium vs. Dementia

Page 41: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Delirium (DSM IV)

1. Disturbed consciousness

2. Change in cognition or perception (not dementia)

3. Acute onset; fluctuation

4. Physiological consequence of medical condition

Source: Cleveland Clinic Center for Geriatric Medicine

Page 42: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Onset shortly after admission to hospital

Hyperactive Hypoactive Mixed

• Increased psychomotor

activity

• Rapid speech

• Irritability

• Restlessness

• Paranoia

• Lethargy

• Slowed speech

• Decreased alertness

• Apathy

• Too polite

• Change between hyperactive and hypoactive states within the shift

Variable, unpredictable course and may persist for several weeks after

discharge

Delirium Clinical Presentation

Presenter
Presentation Notes
There are 3 clinical subtypes of delirium: Hyperactive Hypoactive Mixed Hyperactive patients show increased psychomotor activity, such as rapid speech, irritability, and restlessness. Nurses typically associate delirium with hyperactivity and patient behaviors that are disruptive, time-consuming, and harmful. Therefore, patients with delirium who are hyperactive may be more readily identified and treated. Hypoactive patients exhibit symptoms of lethargy, slowed speech, decreased alertness, and apathy. These patients do not disrupt care or others and may go unidentified or misdiagnosed as being depressed. Patients with mixed delirium shift between hyperactive and hypoactive states. When this occurs, staff may assume that the patient’s condition has improved, when it has actually worsened. This fluctuating pattern and unpredictability makes daily management and staff allocation difficult. The onset of delirium generally occurs shortly after admission, has a varied and unpredictable course, and may persist for several weeks after discharge. The duration of delirium depends in part on how quickly its causes are identified and treated.
Page 43: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Delirium: Precipitating Factors Surgical: Type surgery; Intra-operative blood loss; post-op anemia Medical: Severity illness; restraints; psychotropic drug(s); > 3 medications; bladder catheter; iatrogenic event

Predisposing Factors

Pro

tect

ive

Fact

ors

Young Healthy High functional Status

Old Sensory impaired

Cognitive impaired Malnourished

Dehydration Depression

Prior delirium

Inouye 1996. Marcantonio. 1994, 1998. Fricchione. 2008. Cerejeira. Nurs Res. Pract. 2011

Page 44: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Differentiate Delirium vs. Dementia

Parameter Delirium Dementia

Onset Short, rapid, hours/days Insidious and gradual

Presentation Disoriented, fluctuating moods

Vague symptoms, loss of intellect, agitated, aggressive

Course Hours, weeks, or longer Slow and continuous

Sleep/Wake Worse at night in darkness

and on awakening, insomnia

Worse in evening; “sundowning”, reversed sleep

Duration Hours to < month Month to years

Affect Labile variable; fear/panic, euphoria, disturbed

Easily distracted, inappropriate anxiety, labile to apathy

NICHE Geriatric Resource Nurse Training: Core Curriculum

Page 45: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Differentiate Delirium vs. Dementia

NICHE Geriatric Resource Nurse Training: Core Curriculum

Parameter Delirium Dementia

Judgment Impaired; difficulty

separating facts and hallucinations

Impaired, bad/inappropriate decisions, denies problems

Psychotic symptoms Delusions

Misperceives people and events as threatening; late delusions, hallucinations

Level of Consciousness Disturbed Intact

Recent Memory Impaired, but remote memory is intact

Short term memory deficit in early course, progresses to

long-term deficits, confabulation, perseveration

Page 46: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Most common emotional disorder

• Mild to severe forms

• Symptoms – Depressed mood – Associated psychological symptoms – Somatic manifestations – Suicidal thoughts or attempts – Psychotic symptoms

Depression in Older Adults

Presenter
Presentation Notes
Depression is the most common emotional disorder found in older adults. It causes suffering for patients and their families, interferes with a person’s ability to function, exacerbates coexisting medical illnesses, and increases utilization of health services. Depression is not a natural part of aging or a normal reaction to acute illness and hospitalization. Depression may range in severity from mild symptoms to more severe forms. Suicidal ideation, psychotic features, and excessive somatic concerns frequently accompany more severe forms of depression. Symptoms of anxiety frequently coexist with depression in older adults.
Page 47: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

1. Depressed, sad, or irritable mood

2. Diminished pleasure in people/activities

3. Feelings of worthlessness, self reproach, excessive guilt

4. Difficulty thinking or diminished concentration

5. Suicidal thinking or attempts

6. Fatigue and loss of energy

7. Changes in appetite & weight

8. Disturbed sleep

9. Psychomotor agitation or retardation

Criteria

Presenter
Presentation Notes
The DSM-IV-TR criteria for depression are: 1. depressed, sad, or irritable mood 2. diminished pleasure in pleasurable people/activities 3. feelings of worthlessness, self reproach, excessive guilt 4. difficulty thinking or diminished concentration 5. suicidal thinking or attempts 6. fatigue and loss of energy 7. changes in appetite & weight 8. disturbed sleep 9. psychomotor agitation or retardation
Page 48: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Common Together

• Cause and effect unknown

• “Pseudodementia” – Major depression misdiagnosed as dementia – slow to answer questions – Many non-responses – “I don’t know” responses

• Depression may also be mistaken for hypoactive delirium

Depression and Cognitive Impairment

Source: At home personal care

Page 49: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Does the Type of Dementia Really Matter?

Source: MS clipart

Page 50: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Patients with dementia have difficulty – Identifying changes in health status – Describing symptoms of co-morbid conditions – Asking clearly for pain relief – Comprehending instructions – Following directions for self care and safety

• Are more vulnerable to stress when making transitions in care

Consequences

Presenter
Presentation Notes
Patients with dementia have difficulty: identifying changes in health status describing symptoms of co-morbid conditions asking clearly for pain relief comprehending instructions following directions for self care and safety Older adults with dementia are particularly vulnerable to stress when making transitions in care.
Page 51: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Nemanda – Newest drug to treat AD reverses the damage done to the brain

• High doses of Vitamin E – Has shown to be beneficial to people with dementia

• Estrogen – Recommended for postmenopausal women to prevent

development of AD

• NSAIDs – Have been shown to be effective in slowing the progression of

dementia

Truth vs. Myth - Treatment

Page 52: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Cholinesterase Inhibitors

• Tacrine (Cognex)- Off market in USA

• Donepezil (Aricept)

• Rivastigmine (Exelon)

• Galantamine (Razadyne)

• Memantine (Nemanda)

Treatment - Pharmacology

Presenter
Presentation Notes
Cholinesterase Inhibitors Support communication among nerve cells by keeping acetylcholine levels high. On average, delay worsening of symptoms for 6 to 12 months for about half the people who take them. Some experts believe a small percentage of people may benefit more dramatically. Memantine (Namenda) works by regulating the activity of glutamate, a different messenger chemical involved in learning and memory. Memantine: Was approved in 2003 for treatment of moderate to severe Alzheimer's disease. Is currently the only drug of its type approved to treat Alzheimer's. Temporarily delays worsening of symptoms for some people. Many experts consider its degree of benefit is similar to the cholinesterase inhibitors.
Page 53: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Phosphatidylserine

• Coral calcium

• Tramiprosate

• Coenzyme Q10

• Ginkgo biloba

• Huperzine A

• Omega-3 fatty acids

• Medical foods - Caprylic acid / Axona

Alternative Treatments

Source: alzheimer’s association

Presenter
Presentation Notes
Coenzyme Q10, or ubiquinone, is an antioxidant that occurs naturally in the body and is needed for normal cell reactions. This compound has not been studied for its effectiveness in treating Alzheimer’s. A synthetic version of this compound, called idebenone, was tested for Alzheimer’s disease but did not show favorable results. Little is known about what dosage of coenzyme Q10 is considered safe, and there could be harmful effects if too much is taken. “Coral” calcium supplements have been heavily marketed as a cure for Alzheimer’s disease, cancer and other serious illnesses. Coral calcium is a form of calcium carbonate claimed to be derived from the shells of formerly living organisms that once made up coral reefs.�In June 2003, the Federal Trade Commission (FTC) and the Food and Drug Administration (FDA) filed a formal complaint against the promoters and distributors of coral calcium. The agencies state that they are aware of no competent and reliable scientific evidence supporting the exaggerated health claims and that such unsupported claims are unlawful.�Ginkgo biloba is thought to have both antioxidant and anti-inflammatory properties, to protect cell membranes and to regulate neurotransmitter function. Ginkgo has been used for centuries in traditional Chinese medicine and currently is being used in Europe to alleviate cognitive symptoms associated with a number of neurological conditions. Large clinical trials showed no benefit Huperzine A (pronounced HOOP-ur-zeen) is a moss extract that has been used in traditional Chinese medicine for centuries. It has properties similar to those of cholinesterase inhibitors, one class of FDA-approved Alzheimer medications. As a result, it is promoted as a treatment for Alzheimer's disease. Beneficial in some small trials Omega- 3 fatty acids Theories about why omega-3s might influence dementia risk include their benefit for the heart and blood vessels; anti-inflammatory effects; and support and protection of nerve cell membranes. There is also preliminary evidence that omega-3s may also be of some benefit in depression and bipolar disorder (manic depression PhsphatidyserineThe theory behind treatment with phosphatidylserine is its use may shore up the cell membrane and possibly protect cells from degenerating. The first clinical trials with phosphatidylserine were conducted with a form derived from the brain cells of cows. Some of these trials had promising results.
Page 54: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Phosphatidylserine

• Coral calcium

• Tramiprosate

• Coenzyme Q10

• Ginkgo biloba

• Huperzine A

• Omega-3 fatty acids

• Medical foods- Caprylic acid/ Axona -

Alternative Treatments

Source: alzheimer’s association

Presenter
Presentation Notes
Coenzyme Q10, or ubiquinone, is an antioxidant that occurs naturally in the body and is needed for normal cell reactions. This compound has not been studied for its effectiveness in treating Alzheimer’s. A synthetic version of this compound, called idebenone, was tested for Alzheimer’s disease but did not show favorable results. Little is known about what dosage of coenzyme Q10 is considered safe, and there could be harmful effects if too much is taken. “Coral” calcium supplements have been heavily marketed as a cure for Alzheimer’s disease, cancer and other serious illnesses. Coral calcium is a form of calcium carbonate claimed to be derived from the shells of formerly living organisms that once made up coral reefs.�In June 2003, the Federal Trade Commission (FTC) and the Food and Drug Administration (FDA) filed a formal complaint against the promoters and distributors of coral calcium. The agencies state that they are aware of no competent and reliable scientific evidence supporting the exaggerated health claims and that such unsupported claims are unlawful.�Ginkgo biloba is thought to have both antioxidant and anti-inflammatory properties, to protect cell membranes and to regulate neurotransmitter function. Ginkgo has been used for centuries in traditional Chinese medicine and currently is being used in Europe to alleviate cognitive symptoms associated with a number of neurological conditions. Large clinical trials showed no benefit Huperzine A (pronounced HOOP-ur-zeen) is a moss extract that has been used in traditional Chinese medicine for centuries. It has properties similar to those of cholinesterase inhibitors, one class of FDA-approved Alzheimer medications. As a result, it is promoted as a treatment for Alzheimer's disease. Beneficial in some small trials . Phase 3 trials showed now benefit- dangerous to take with Cholinesterase inhibitor Omega- 3 fatty acids Theories about why omega-3s might influence dementia risk include their benefit for the heart and blood vessels; anti-inflammatory effects; and support and protection of nerve cell membranes. There is also preliminary evidence that omega-3s may also be of some benefit in depression and bipolar disorder (manic depression MEDICAL FOOD_ AXONA�Caprylic acid is the active ingredient of Axona, which is marketed as a “medical food.” Caprylic acid is a medium-chain triglyceride (fat) produced by processing coconut oil or palm kernel oil.
Page 55: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Regular physical exercise

• Mental stimulating activity

• Socialization

• Diet – High in antioxidants – Mediterranean

Nonpharmacological Interventions

Presenter
Presentation Notes
Maintaining physical and functional well being facilitates independence, maintains, health status, and can ease the caregiver burden. Interventions include adequate nutrition and hydration, regular exercise, maintenance of ADLs, proper rest and sleep, appropriate bowel and bladder routines, proper dental hygiene and care, and current vaccinations. Because co-morbidities are common, regular assessment, monitoring, and aggressive management of acute and chronic conditions are necessary.
Page 56: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• 68 yo man brought to office by family for concerns about behavior change, angry and irritable alternating with periods of pronounced apathy, repetitiveness, misplacing things, poor judgement, poor behavioral control, gradual onset over 4 years

• PMH – HTN, OA

• Medications – Lisinopril, HCTZ

• Social history – Rare ETOH, no smoking or ilicit drugs – Physically active – 12 years education

Mr. B

Page 57: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• MMSE 22 / 30 – Deficits in ST memory and executive function

• MOCA 13 / 30 – CT scan - mild atrophy and small amount of white matter changes

• What next ?

Evaluation

Page 58: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

PREVENTION Healthy is Brain Healthy

• Healthy brain initiative

• Diet

• Exercise

• No smoking

• Avoid alcohol

• Manage cholesterol

• Manage diabetes

Page 59: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• People with fewer years of education are at higher risk for Alzheimer’s and other dementias

• ? more years of education builds a “cognitive reserve” that enables individuals to better compensate

• Cognitive reserve hypothesis -education increases the connections between neurons

• Learn a new language

• Learn to play on instrument

• ? Benefit of mentally stimulating computer games – Luminosity

Cognitive Reserve – Education – Mentally Stimulating Activity

Page 60: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Lifetime of complex mental activities decreased the risk of dementia by 50% – Reading – Socially active – Inquisitive – Avoiding routine

• It’s never to late to start exercising the brain

Mental Exercises / Neurobotics

Page 61: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Which of the following two words are most opposite in meaning?

– Irrational, pleasing, privy, wise, perceptible

• Which of the following two words are closest in meaning?

– Change, stereotype, delete, pigeonhole, identify

Mind Exercise

Page 62: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• Which of the following two words are most opposite in meaning?

– Irrational, pleasing, privy, wise, perceptible

• Which of the following two words are closest in meaning?

– Change, stereotype, delete, pigeonhole, identify

Mind Exercise

Page 63: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

• More to come – Role of imaging and biomarkers on diagnosis

• Vaccination

• Use of inhaled Insulin

• Lifestyle – Diet, mental and physical activity

Future Directions

Page 64: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Source: braiden .com face illusions

Page 65: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

Healthy Aging

• ngm.nationalgeographic.com/ngm/0511/sights_n_sounds/index.html

Page 66: Neurocognitive Disorders: Cognition and Aging · •58 year old woman presents to clinic with chief complaint of memory loss. • She reports having difficulty remembering appointments,

DOS CME Course 2011 66